|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Amortization of operating lease right-of-use assets | |||||
| Loss on impairment of assets | |||||
| Loss (gain) on sales and disposal of subsidiaries, property and equipment and leases, net | |||||
| Non-cash interest expense | |||||
| Non-cash share-based compensation expense | |||||
| Bad debt expense | |||||
| Deferred income taxes | |||||
| Unrealized foreign currency exchange loss (gain) | |||||
| Non-cash loss from non-income tax contingencies | |||||
| Loss on debt extinguishment | |||||
| Payments for lease settlements | |||||
| Other, net | |||||
| Loss on derivative instruments | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Income tax receivable/payable, net | |||||
| Deferred revenue and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Expenditures for deferred costs | |||||
| Receipts from sales of discontinued operations, net of cash sold, property and equipment | |||||
| Settlement of derivatives related to sale of discontinued operations and net investment hedge | |||||
| Receipts from sales of property and equipment | |||||
| Net receipts (payments) related to sales of discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of long-term debt, net of original issue discount | |||||
| Payments on long-term debt | |||||
| Payments to purchase noncontrolling interests | |||||
| Payments of dividend equivalent rights and special dividends | |||||
| Proceeds from exercise of stock options | |||||
| Payments to repurchase common stock and excise tax payments | |||||
| Withholding of shares to satisfy tax withholding for vested stock awards and exercised stock options | |||||
| Payment of debt issuance costs | |||||
| Net cash used in financing activities | |||||
| Effects of exchange rate changes on Cash and cash equivalents and Restricted cash | |||||
| Change in cash included in current assets held for sale | |||||
| Net change in Cash and cash equivalents and Restricted cash | |||||
| Cash and cash equivalents and Restricted cash at beginning of period | |||||
| Cash and cash equivalents and Restricted cash at end of period | |||||
Loading...